نتایج جستجو برای: phenotypic assays

تعداد نتایج: 173924  

2014
Birgit T. Priest Gul Erdemli

Since the advent of molecular cloning, target based screening has become the norm in pharmaceutical drug discovery. A large number of potential drug targets have been cloned and functionally expressed, and enormous progress has been made in the development, miniaturization and automation of cell based assays on target molecules recombinantly expressed in mammalian cell lines. This approach has ...

Journal: :Plant physiology 2008
Yan Lu Linda J Savage Imad Ajjawi Kathleen M Imre David W Yoder Christoph Benning Dean Dellapenna John B Ohlrogge Katherine W Osteryoung Andreas P Weber Curtis G Wilkerson Robert L Last

In traditional mutant screening approaches, genetic variants are tested for one or a small number of phenotypes. Once bona fide variants are identified, they are typically subjected to a limited number of secondary phenotypic screens. Although this approach is excellent at finding genes involved in specific biological processes, the lack of wide and systematic interrogation of phenotype limits ...

2010
Samuel J. Balin Marilia Cascalho

The rate of mutation refers to the probability that a unit length of DNA (generally a base pair) mutates with time. Fluctuation analysis or mutant accumulation assays applied to phenotypic changes measure mutation rates of cells. However, only a few phenotypic changes indicative of mutations are known thus limiting the analysis to those rare genes. Direct sequencing overcomes the limitations im...

2015
Jonathan A. Lee Paul Shinn Susan Jaken Sarah Oliver Francis S. Willard Steven Heidler Robert B. Peery Jennifer Oler Shaoyou Chu Noel Southall Thomas S. Dexheimer Jeffrey Smallwood Ruili Huang Rajarshi Guha Ajit Jadhav Karen Cox Christopher P. Austin Anton Simeonov G. Sitta Sittampalam Saba Husain Natalie Franklin David J. Wild Jeremy J. Yang Jeffrey J. Sutherland Craig J. Thomas Bridget Wagner

Phenotypic assays have a proven track record for generating leads that become first-in-class therapies. Whole cell assays that inform on a phenotype or mechanism also possess great potential in drug repositioning studies by illuminating new activities for the existing pharmacopeia. The National Center for Advancing Translational Sciences (NCATS) pharmaceutical collection (NPC) is the largest re...

2009
Jonathan Low Arunava Chakravartty Wayne Blosser Michele Dowless Christopher Chalfant Patty Bragger Louis Stancato

Phenotypic drug discovery, primarily abandoned in the 1980's in favor of targeted approaches to drug development, is once again demonstrating its value when used in conjunction with new technologies. Phenotypic discovery has been brought back to the fore mainly due to recent advances in the field of high content imaging (HCI). HCI elucidates cellular responses using a combination of immunofluor...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید